Medizinische Universität Graz - Research portal
Schlintl Verena |
** = Publications listed in SCI/SSCI/Pubmed
2024
Full paper/article (Journal)
** Hochmair, M; Terbuch, A; Lang, D; Trockenbacher, C; Augustin, F; Ghanim, B; Maurer, D; Taghizadeh, H; Kamhuber, C; Wurm, R; Lindenmann, J; Braz, P; Bundalo, T; Begic, M; Bauer, J; Reimann, P; Müser, N; Huemer, F; Schlintl, V; Bianconi, D; Baumgartner, B; Schenk, P; Rauter, M; Hötzenecker, K
Real-World Treatment Patterns and Timeliness of Clinical Care Pathway for Non-Small Cell Lung Cancer Patients in Austria: The PRATER Retrospective Study.
Cancers (Basel). 2024; 16(14):
Doi: 10.3390/cancers16142586
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** John, N; Schlintl, V; Sassmann, T; Lindenmann, J; Fediuk, M; Wurm, R; Douschan, P; Zacharias, M; Kalson, L; Posch, F; Absenger, G; Brcic, L; Jost, PJ; Terbuch, A
Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLC.
J Immunother Cancer. 2024; 12(4):
Doi: 10.1136/jitc-2023-008592
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Terbuch, A; Konjic, S; Schlintl, V; Absenger, G; Jost, PJ; Lindenmann, J; Swatek, P; John, N; John, T; Wurm, R; Zacharias, M; Posch, F; Hochmair, MJ; Fabikan, H; Weinlinger, C; Illini, O; Horvath, L; Gamerith, G; Wolf, D; Augustin, F; Brcic, L
Prognostic impact of targetable driver alterations in resected early-stage lung cancer.
Transl Lung Cancer Res. 2024; 13(11): 3096-3105.
Doi: 10.21037/tlcr-24-433
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Hochmair, M; Terbuch, A; Lang, D; Trockenbacher, C; Augustin, F; Ghanim, B; Maurer, D; Taghizadeh, H; Kamhuber, C; Wurm, R; Lindenmann, J; Braz, P; Bundalo, T; Begic, M; Bauer, J; Reimann, P; Müser, N; Huemer, F; Schintl, V; Bianconi, D; Baumgartner, B; Schenk, P; Rauter, M; Hötzenecker, K
Real-world characteristics and treatment patterns of patients with early-stage non-small cell lung cancer in Austria: the PRATER retrospective study
WIEN KLIN WOCHENSCHR. 2024; 136: S530-S531.
[Poster]
Web of Science
FullText
2023
Full paper/article (Journal)
** Barth, DA; Moik, F; Steinlechner, S; Posch, F; Mayer, MC; Sandner, AM; Berton, F; Schlintl, V; Koch, L; John, N; Wurm, R; Pichler, M; Bauernhofer, T; Reimann, P; Wohlkönig, C; Richtig, E; Winder, T; Preusser, M; Jost, PJ; Ay, C; Gerger, A; Terbuch, A; Riedl, JM
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study.
J Immunother Cancer. 2023; 11(12):
Doi: 10.1136/jitc-2023-007765
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Huemer, F; Hecht, S; Scharinger, B; Schlintl, V; Rinnerthaler, G; Schlick, K; Heregger, R; Melchardt, T; Wimmer, A; Mühlbacher, I; Koch, OO; Neureiter, D; Klieser, E; Seyedinia, S; Beheshti, M; Greil, R; Weiss, L
Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol.
J Cancer Res Clin Oncol. 2023; 149(7):3051-3064
Doi: 10.1007/s00432-022-04096-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Barth, D; Moik, F; Steinlechner, SM; Posch, F; Schlintl, V; Koch, L; John, N; Wurm, R; Pichler, M; Bauernhofer, T; Reimann, P; Wohlkönig, C; Richtig, E; Winder, T; Preusser, M; Jost, PJ; Ay, C; Gerger, A; Terbuch, A; Riedl, JM
Early kinetics of C-reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: A multi-center cohort study
ANN ONCOL. 2023; 34: S259-S259.-Annual Meeting of the European-Society-for-Medical-Oncology (ESMO); OCT 20-24, 2023; Barcelona, SPAIN.
Doi: 10.1016/j.annonc.2023.09.2917
[Poster]
Web of Science
FullText
FullText_MUG
2022
Full paper/article (Journal)
** Schlintl, V; Huemer, F; Rinnerthaler, G; Melchardt, T; Winder, T; Reimann, P; Riedl, J; Amann, A; Eisterer, W; Romeder, F; Piringer, G; Ilhan-Mutlu, A; Wöll, E; Greil, R; Weiss, L
Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort.
BMC Cancer. 2022; 22(1):51
Doi: 10.1186/s12885-021-09115-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Riedl, JM; Barth, D; Steinlechner, S; Moik, F; Posch, F; Schlintl, V; Mayer, MC; Sandner, AM; Berton, F; Koch, L; John, N; Wurm, R; Pichler, M; Absenger, G; Jost, PJ; Wohlkonig, C; Richtig, E; Winder, T; Gerger, A; Terbuch, A
Early CRP Kinetics after Initiation of Immune Checkpoint Inhibitors is a predictive Biomarker for Treatment Response independent of the Tumor Antity
ONCOL RES TREAT. 2022; 45(SUPPL 2):228-228.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; Okt 7-10, 2022; Wien.
[Poster]
Web of Science
** Zacharias, M; Konjic, S; Absenger, G; Hochmair, MJ; Fabikan, H; Weinlinger, C; Illini, O; Jost, PJ; Schlintl, V; Wurm, R; Lindenmann, J; Fediuk, M; Brcic, L; Terbuch, A
Clinicopathological Features of Rare but Targetable Mutations in Surgically Resected Lung Carcinomas
J THORAC ONCOL. 2022; 17(9): S201-S202.
[Poster]
Web of Science
2020
Full paper/article (Journal)
** Huemer, F; Klieser, E; Neureiter, D; Schlintl, V; Rinnerthaler, G; Pagès, F; Kirilovsky, A; El, Sissy, C; Iglseder, W; Singhartinger, F; Jäger, T; Dinnewitzer, A; Zaborsky, N; Steiner, M; Greil, R; Weiss, L
Impact of PD-L1 Scores and Changes on Clinical Outcome in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
J Clin Med. 2020; 9(9):
Doi: 10.3390/jcm9092775
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Huemer, F; Piringer, G; Schlintl, V; Hackl, H; Rinnerthaler, G; Thaler, J; Greil, R; Weiss, L
Hospitalizations and Clinical Outcome in Metastatic Colorectal Cancer During Regorafenib or TAS-102 Therapy.
Cancers (Basel). 2020; 12(10):
Doi: 10.3390/cancers12102812
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG